Daily Vaginal Application of Dienogest (Visanne©) for 3 Months in Symptomatic Deeply Infiltrating Rectovaginal Endometriosis: A Possible New Treatment Approach?
A 27-year-old patient suffering from deeply infiltrating rectovaginal endometriosis was treated with 2 mg/day dienogest vaginally for 3 months. The therapy was tolerated very well. The patient reported less side effects compared to the oral use of dienogest. After 3 months of dienogest treatment, th...
Saved in:
Main Author: | Andreas D. Ebert (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2018-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Uterine rupture following laparoscopic excision of deeply invasive rectovaginal endometriosis: Is it the song or the singer?
by: Ceana Nezhat, M.D, et al.
Published: (2020) -
Evaluation of Deeply Infiltrating Endometriosis by Preoperative Magnetic Resonance Imaging in Patients with Adenomyosis
by: Kanako Yoshida, et al.
Published: (2024) -
Efficacy and safety of long-term administration of dienogest for deep infiltrative endometriosis
by: Volkov V.G, et al.
Published: (2019) -
Manejo laparoscópico de la endometriosis del septo rectovaginal Laparoscopic management of rectovaginal septum endometriosis
by: Jaime Saavedra
Published: (2003) -
Dienogest in long-term treatment of endometriosis
by: Schindler AE
Published: (2011)